GSK, CureVac partnership eyes COVID-19 vaccine against multiple variants

GSK, CureVac partnership eyes COVID-19 vaccine against multiple variants In a joint statement on Wednesday, the partners said they were targeting a possible launch in 2022.

No comments:

Post a Comment